NDC Compounded Drug 71266-9160-2 Bupivacaine Hydrochloride
Injection Perineural
Compounded Drug Product Information
Frequently Asked Questions
What is the NDC number assigned to Bupivacaine?
Bupivacaine was assigned by its manufacturer with NDC product code 71266-9160. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Bupivacaine?
The NDC package code 71266-9160-2 was assigned to a 10 mL in 1 SYRINGE, PLASTIC of bupivacaine hydrochloride administered perineural via injection.
Who manufactures this product?
Bupivacaine is manufactured by an outsourced facility and labeled by Fagron Compounding Services Llc Dba Fagron Sterile Services Llc Dba Jcb Laboratories. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.